Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens.
about
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfallsTargeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancerDetecting ultralow-frequency mutations by Duplex Sequencing.Molecular digital pathology: progress and potential of exchanging molecular data.StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.Targeted Enrichment for Pathogen Detection and Characterization in Three Felid SpeciesDetection of gene rearrangements in targeted clinical next-generation sequencing.A method to evaluate genome-wide methylation in archival formalin-fixed, paraffin-embedded ovarian epithelial cellsValidation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trailEvaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.Emerging understanding of multiscale tumor heterogeneityPerformance of common analysis methods for detecting low-frequency single nucleotide variants in targeted next-generation sequence dataNext-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue.Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnosticsMassively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy.Amplicon sequencing of colorectal cancer: variant calling in frozen and formalin-fixed samples.Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNARobustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.Mining the Archives: A Cross-Platform Analysis of Gene Expression Profiles in Archival Formalin-Fixed Paraffin-Embedded Tissues.Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency.Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue SamplesClinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded MaterialBuilding a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene TestingSingle-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNASpatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.Next-Generation Sequencing to Guide Clinical Trials.Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.High-throughput detection of clinically targetable alterations using next-generation sequencing.LoLoPicker: detecting low allelic-fraction variants from low-quality cancer samples.Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China.Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities.
P2860
Q27853005-A0CFB351-30EB-42F9-B533-8FF536218C30Q28066709-AC57E6F4-8AF8-4382-A261-CF88AC60E7EAQ28273722-4ED6B9C1-C330-4C25-999D-7ED1DEDA69A8Q30413211-415BE262-AB27-4E32-9081-3CC410F995A6Q31118370-89EC9D52-E31D-43D6-AE94-40DA765DD355Q33679597-DD67815E-728C-4A46-8843-0C8ABF46C62BQ33721505-126C9C3A-0AF9-4369-B269-7ADD6E524740Q33833183-AF41D363-2381-4DE9-80C3-6128E1EE2C7FQ34061399-3B920542-5B69-49BB-8B20-9B678D7D9463Q34113504-F3481D95-0828-4234-85C6-A376AB54A6D9Q34560270-3BC791A5-CA7C-464E-8FE1-E6374A9DED01Q34730000-8AF3865C-C65B-4770-8DFA-304DF8E6AC3CQ35037810-690F385F-FB06-42CA-81F5-01201B1500E8Q35176679-8E69DBFB-A9B2-434E-B044-6C76E24ED6DDQ35178113-807A5D7C-AEB6-4D27-B9EF-2276DF229C9FQ35221918-6077DE0E-D3D0-4E7E-B4CB-498A9199BA79Q35497448-9741505C-2F6F-4726-B51E-BEF69B5467FCQ35641264-42D74AA1-1BE5-4B39-95F1-C93DCD584422Q35651423-7B762876-B384-4426-A399-443D7D4D1BF9Q35722718-7307B317-4C12-4D33-ADA0-AC11F35B64CAQ35771168-38982559-6A7C-4358-866B-5EA0131ABA44Q35772123-67DDD1C0-A80B-4215-9959-8176813D59AAQ35831238-ABC83A7F-DC79-4B0C-8B30-0818F0FBA869Q35852269-C792C3B9-796A-477B-A46B-FF17BC389446Q35862252-725D6178-D137-4311-A838-69DD8154BAF7Q35901968-F90750E7-97C2-4C3F-9CC4-8FDCC0E88D1AQ35937517-0DA78EE8-DEA3-4352-9BF9-9266C46748A6Q35979104-E324FE82-FC9B-4BF1-AA0F-782BA7BB94DDQ36087015-F0C93E25-D332-4B91-8A2D-74E11E1CCD7CQ36167042-1C9ED967-9790-455B-AEE8-EDF99AAF66E4Q36174832-C7E914F1-26EB-4A2E-9183-5EBAC072A057Q36260672-663BC5EE-FE31-4267-992C-85E62A7EA9CEQ36345358-91EF4A47-A29A-4C13-ACE0-08F0349322EBQ36349170-24B85EFF-9316-4653-AD39-DBFFDF320596Q36412413-15F623B9-F35A-481B-B29C-22CCAD3395FEQ36441399-FBB7C002-3AEA-4A32-B514-450DEE9C1C94Q36905641-D67A6E2B-E72B-4E34-B4B5-587AE6D33514Q37327426-3417F38C-681F-4A50-9E12-416CBE345D61Q37629053-07FB24F6-C179-4302-813F-3200EF24EDBFQ38150909-3BD7C1FF-95D5-4838-81E3-6F66DD5FBF78
P2860
Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@ast
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@en
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@nl
type
label
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@ast
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@en
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@nl
prefLabel
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@ast
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@en
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@nl
P2093
P2860
P1476
Comparison of clinical targete ...... fresh-frozen tissue specimens.
@en
P2093
David H Spencer
Eric J Duncavage
Haley J Abel
Jennifer K Sehn
John D Pfeifer
Mark A Watson
P2860
P304
P356
10.1016/J.JMOLDX.2013.05.004
P577
2013-06-26T00:00:00Z